# Gyre Therapeutics, Inc.: Form 8-K, filed Nov 27, 2024

- Company: [Gyre Therapeutics, Inc.](/companies/gyre.md) (CIK 1124105)
- Form: 8-K
- Filed: 2024-11-27
- Accepted by EDGAR: Nov 27, 2024, 16:25 ET
- Period: 2024-11-27
- Accession: 0001140361-24-047980
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/ny20036484x4_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/ny20036484x4_8k.htm

Filed Nov 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-047980. Last ingested by Listed: Nov 5, 2026, 18:44 ET. No prices; not investment advice.